OOIR: Observatory of International Research

Papers

(The H4-Index of Diabetes Metabolic Syndrome and Obesity-Targets and Therapy is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
A Review of Current Trends with Type 2 Diabetes Epidemiology, Aetiology, Pathogenesis, Treatments and Future Perspectives	202
Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products	157
<p>Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus</p>	112
Custom-Molded Offloading Footwear Effectively Prevents Recurrence and Amputation, and Lowers Mortality Rates in High-Risk Diabetic Foot Patients: A Multicenter, Prospective Observational Study	62
Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations	54
Artificial Flora Algorithm-Based Feature Selection with Gradient Boosted Tree Model for Diabetes Classification	51
Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1	49
Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges	43
Relationship Between the TyG Index and Diabetic Kidney Disease in Patients with Type-2 Diabetes Mellitus	41
The Association Between Obesity and Social Isolation as Well as Loneliness in the Adult Population: A Systematic Review	39
Compositional Alterations of Gut Microbiota in Patients with Diabetic Kidney Disease and Type 2 Diabetes Mellitus	39
Oral Health Messiers: Diabetes Mellitus Relevance	38
Emodin Ameliorates Renal Damage and Podocyte Injury in a Rat Model of Diabetic Nephropathy via Regulating AMPK/mTOR-Mediated Autophagy Signaling Pathway	37
Circulating miR-30a-5p and miR-182-5p in Prediabetes and Screen-Detected Diabetes Mellitus	34
The Profile and Function of Gut Microbiota in Diabetic Nephropathy	34
Remnant Cholesterol is an Independent Predictor of New-Onset Diabetes: A Single-Center Cohort Study	34
Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk	33
Metabolomic Signature Between Metabolically Healthy Overweight/Obese and Metabolically Unhealthy Overweight/Obese: A Systematic Review	33
Atorvastatin Regulates MALAT1/miR-200c/NRF2 Activity to Protect Against Podocyte Pyroptosis Induced by High Glucose	32
Association Between Gut Akkermansia and Metabolic Syndrome is Dose-Dependent and Affected by Microbial Interactions: A Cross-Sectional Study	31
Molecular Functions of Ceruloplasmin in Metabolic Disease Pathology	31
<p>Dyslipidemia and Its Associated Risk Factors Among Adult Type-2 Diabetic Patients at Jimma University Medical Center, Jimma, Southwest Ethiopia</p>	30
Risk Factors for Major Amputation in Diabetic Foot Ulcer Patients	30
Revisional Surgeries of Laparoscopic Sleeve Gastrectomy	30
Prevalence of Overweight and Obesity, and Its Associated Factors Among Health-care Workers, Teachers, and Bankers in Arusha City, Tanzania	28

Impact of Cognitive Impairment on Adherence to Treatment and Self-Care in Patients with Type 2 Diabetes Mellitus	28
The Association Between Sarcopenic Obesity and Hypertension, Diabetes, and Abnormal Lipid Metabolism in Chinese Adults	28
Effects of Short-Term Dietary Fiber Intervention on Gut Microbiota in Young Healthy People	27
The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction	27
The Relationship Between the Blood-Brain-Barrier and the Central Effects of Glucagon-Like Peptide-1 Receptor Agonists and Sodium-Glucose Cotransporter-2 Inhibitors	27
The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy	27
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Predict Mortality in Patients with Diabetic Foot Ulcers Undergoing Amputations	27
Psychosocial Determinants of Treatment Adherence in Patients with Type 2 Diabetes – A Review	27